SEC Form 4 · accession 0001093557-17-000103
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrance H Gregg
Officer — Executive Chairman · Director
Period of report
Apr 20, 2017
Accepted (ET)
Apr 24, 2017 · 6:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 20, 2017 | S | 15,000 | $74.10 | D | 40,882 | I | by Trust |
| Common Stock | holding | — | — | — | 454,559 | D | ||
| Common Stock | holding | — | — | — | 11,461 | I | by IRA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person contributed Dexcom, Inc. Common Stock to an exchange fund, pursuant to an agreement dated March 13, 2017 to contribute shares of DexCom, Inc. Common Stock in exchange for shares of the exchange fund. The Dexcom, Inc. Common Stock was valued at $74.10 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person with respect to the April 20, 2017 closing of the exchange fund.
- F2Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.